Proposal for the Enantioselective Total Synthesis of N-Methylwelwitindolinone C I

N-甲基二氢吲哚啉酮 C I 对映选择性全合成方案

基本信息

  • 批准号:
    8384843
  • 负责人:
  • 金额:
    $ 4.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-11-15 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Multiple drug resistant (MDR) carcinomas represent an urgent and growing problem in the field of human health. Because these cancer phenotypes respond poorly to treatment with known chemotherapeutic agents, there exists a need for novel cytotoxic reagents to combat them. The marine alkaloid N-methylwelwitindolinone C isothiocyanate is well poised to address this situation. Not only has this natural product displayed potent cytotoxic activity against MDR breast cancer cells (MCF-7, IC50=130 nM), but it has also been shown to reverse the drug resistant capacity of these cell lines, making them up to one-hundred fold more susceptible to conventional cancer drugs such as taxol. Because its isolation from natural sources is a painstaking process that affords little material, the total synthesis of N-methylwelwitindolinone C isothiocyanate is poised as an effective technique to access additional quantities of this potent bioactive compound. The research proposed herein describes a novel, concise approach toward the preparation of N- methylwelwitindolinone C isothiocyanate. The project will involve the development of an enantioselective oxidative dearomatization reaction for the coupling of aryl halides with ortho-carboxy phenols. This new method will provide access to enantioenriched cyclohexadienone products bearing all-carbon 1-quaternary stereocenters. By applying this technique to the synthesis of the N-methylwelwitindolinone C isothiocyanate it will be possible to rapidly construct the complex tetracyclic carbon scaffold of the natural product, which will in turn allow expedient preparation of this marine alkaloid.
描述(由申请人提供):多重耐药(MDR)癌是人类健康领域一个紧迫且日益严重的问题。由于这些癌症表型对已知化疗药物的治疗反应不佳,因此需要新的细胞毒性试剂来对抗它们。海洋生物碱n -甲基维氏吲哚酮C异硫氰酸酯可以很好地解决这一问题。这种天然产物不仅对耐多药乳腺癌细胞(MCF-7, IC50=130 nM)显示出强大的细胞毒活性,而且还显示出它可以逆转这些细胞系的耐药能力,使它们对紫杉醇等传统抗癌药物的敏感性提高100倍。因为从天然来源中分离它是一个艰苦的过程,提供的材料很少,所以n -甲基威维吲哚酮C异硫氰酸酯的全合成是一种有效的技术,可以获得额外数量的这种有效的生物活性化合物。本文提出了一种新颖、简洁的方法来制备异硫氰酸N-甲基威维吲哚酮C。该项目将涉及开发芳基卤化物与邻羧基酚偶联的对映选择性氧化脱芳反应。这种新方法将提供具有全碳1-季立体中心的富对映体环己二酮产品的途径。通过将该技术应用于n -甲基威维吲哚酮C异硫氰酸酯的合成,可以快速构建天然产物的复杂四环碳支架,从而方便地制备该海洋生物碱。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An enantioselective total synthesis and stereochemical revision of (+)-citrinadin B.
  • DOI:
    10.1021/ja405548b
  • 发表时间:
    2013-07-31
  • 期刊:
  • 影响因子:
    15
  • 作者:
    Kong K;Enquist JA Jr;McCallum ME;Smith GM;Matsumaru T;Menhaji-Klotz E;Wood JL
  • 通讯作者:
    Wood JL
Synthetic studies toward citrinadin A: construction of the pentacyclic core.
柑橘素 A 的合成研究:五环核心的构建。
  • DOI:
    10.1038/ja.2016.25
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    McCallum,MonicaE;Smith,GenessaM;Matsumaru,Takanori;Kong,Ke;EnquistJr,JohnA;Wood,JohnL
  • 通讯作者:
    Wood,JohnL
Synthetic studies toward the citrinadins: enantioselective preparation of an advanced spirooxindole intermediate.
  • DOI:
    10.1016/j.tet.2014.02.046
  • 发表时间:
    2014-07
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Takanori Matsumaru;Monica E. McCallum;J. A. Enquist;Genessa M. Smith;K. Kong;J. Wood
  • 通讯作者:
    Takanori Matsumaru;Monica E. McCallum;J. A. Enquist;Genessa M. Smith;K. Kong;J. Wood
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John A. Enquist其他文献

John A. Enquist的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John A. Enquist', 18)}}的其他基金

Proposal for the Enantioselective Total Synthesis of N-Methylwelwitindolinone C I
N-甲基二氢吲哚啉酮 C I 对映选择性全合成方案
  • 批准号:
    8001500
  • 财政年份:
    2010
  • 资助金额:
    $ 4.31万
  • 项目类别:
Proposal for the Enantioselective Total Synthesis of N-Methylwelwitindolinone C I
N-甲基二氢吲哚啉酮 C I 对映选择性全合成方案
  • 批准号:
    8205920
  • 财政年份:
    2010
  • 资助金额:
    $ 4.31万
  • 项目类别:

相似国自然基金

Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
  • 批准号:
    21801032
  • 批准年份:
    2018
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
  • 批准号:
    23K26797
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Chemoenzymatic Synthesis of Complex Polycyclic Alkaloids Enabled by A-Ketoglutarate Dependent Iron Enzymes
职业:通过 A-酮戊二酸依赖性铁酶实现复杂多环生物碱的化学酶法合成
  • 批准号:
    2338495
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Continuing Grant
Strategy Driven Synthesis of Complex Alkaloids
复杂生物碱的策略驱动合成
  • 批准号:
    2400232
  • 财政年份:
    2024
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Standard Grant
Synthesis of guanidine alkaloids based on palladium catalyzed cyclization-carbonylation reactions.
基于钯催化环化-羰基化反应合成胍生物碱。
  • 批准号:
    23K06034
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
  • 批准号:
    23H02104
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Anthropogenic change and disease susceptibility in poison frogs: identifying links with diet, skin alkaloids, and the microbiome
毒蛙的人为变化和疾病易感性:确定与饮食、皮肤生物碱和微生物组的联系
  • 批准号:
    2882384
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Studentship
Synthesis of Anticancer Alkaloids on Cancer Cells with Glycosylated Artificial Metalloenzymes
糖基化人工金属酶合成抗癌细胞生物碱
  • 批准号:
    22KJ1525
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Discovery of analgesic diterpenoid alkaloids from medicinal Aconitum plants using a metabolomic approach
使用代谢组学方法从药用乌头植物中发现镇痛二萜生物碱
  • 批准号:
    10629875
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
Excellence in Research: Biosynthetic investigation of manzamine class alkaloids
卓越研究:曼扎明类生物碱的生物合成研究
  • 批准号:
    2302454
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Standard Grant
Transition Metal-Catalyzed Reaction Development Toward the Synthesis of Alkaloids
过渡金属催化生物碱合成反应的进展
  • 批准号:
    2247315
  • 财政年份:
    2023
  • 资助金额:
    $ 4.31万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了